NEW YORK (GenomeWeb News) – The Children's Hospital of Philadelphia (CHOP) and BGI have partnered to conduct large-scale human genome sequencing and bioinformatics analysis at CHOP's Joint Genome Center at Children's Hospital.
The [email protected] partnership will focus on using BGI's next-generation sequencing capabilities and CHOP's biobank and clinical phenotyping resources to discover which genes are involved in rare and common pediatric diseases.
CHOP "has built the largest pediatric biobank in the world, and because many of these samples have been linked to clinical data using an electronic medical record, we can now follow disease processes into adulthood," Hakon Hakonarson, director of the Center for Applied Genomics at Children's Hospital, said in a statement. "Through our partnership with BGI, we now have a clear path forward into the genomics-based personalized medicine arena."
"The ultimate goal is to change the way we diagnose and treat diseases that affect children and families, and our work with BGI is an important first step toward that end," added CHOP's CSO Philip Johnson.
"Given BGI's expertise in genomic sequencing and bioinformatics, we expect our partnership with Children's Hospital and the establishment of the [email protected] Joint Genome Center to lead to significant breakthroughs that may be translated into improved patient care," said Greg Wang, CEO of Cambridge, Mass.-based BGI Americas.